In Silico Models for the Human α4β2 Nicotinic Acetylcholine Receptor

被引:37
|
作者
Haddadian, Esmael J. [1 ]
Cheng, Mary Hongying [2 ]
Coalson, Rob D. [2 ]
Xu, Yan [1 ]
Tang, Pei [1 ,3 ]
机构
[1] Univ Pittsburgh, Sch Med, Dept Anesthesiol, Pittsburgh, PA 15261 USA
[2] Univ Pittsburgh, Dept Chem, Pittsburgh, PA 15260 USA
[3] Univ Pittsburgh, Sch Med, Dept Computat Biol, Pittsburgh, PA 15261 USA
来源
JOURNAL OF PHYSICAL CHEMISTRY B | 2008年 / 112卷 / 44期
基金
美国国家科学基金会;
关键词
D O I
10.1021/jp804868s
中图分类号
O64 [物理化学(理论化学)、化学物理学];
学科分类号
070304 ; 081704 ;
摘要
The neuronal alpha 4 beta 2 nicotinic acetylcholine receptor (nAChR) is one of the most widely expressed nAChR subtypes in the brain. Its subunits have high sequence identity (54 and 46% for alpha 4 and beta 2, respectively) with alpha and beta subunits in Torpedo nAChR. Using the known structure of the Torpedo nAChR as a template, the closed-channel structure of the alpha 4 beta 2 nAChR was constructed through homology modeling. Normal-mode analysis was performed on this closed structure and the resulting lowest frequency mode was applied to it for a "twist-to-open" motion, which increased the minimum pore radius from 2.7 to 3.4 angstrom and generated an open-channel model. Nicotine could bind to the predicted agonist binding sites in the open-channel model but not in the closed one. Both models were subsequently equilibrated in a ternary lipid mixture via extensive molecular dynamics (MD) simulations. Over the course of 11 ns MD simulations, the open channel remained open with filled water, but the closed channel showed a much lower water density at its hydrophobic gate comprised of residues alpha 4-V259 and alpha 4-L263 and their homologous residues in the beta 2 subunits. Brownian dynamics simulations of Na+ permeation through the open channel demonstrated a current-voltage relationship that was consistent with experimental data on the conducting state of alpha 4 beta 2 nAChR. Besides establishment of the well-equilibrated closed- and open-channel alpha 4 beta 2 structural models, the MD simulations on these models provided valuable insights into critical factors that potentially modulate channel gating. Rotation and tilting of TM2 helices led to changes in orientations of pore-lining residue side chains. Without concerted movement, the reorientation of one or two hydrophobic side chains could be enough for channel opening. The closed- and open-channel structures exhibited distinct patterns of electrostatic interactions at the interface of extracellular and transmembrane domains that might regulate the signal propagation of agonist binding to channel opening. A potential prominent role of the beta 2 subunit in channel gating was also elucidated in the study.
引用
收藏
页码:13981 / 13990
页数:10
相关论文
共 50 条
  • [41] Modeling Differential Binding of α4β2 Nicotinic Acetylcholine Receptor with Agonists and Antagonists
    Huang, Xiaoqin
    Zheng, Fang
    Zhan, Chang-Guo
    JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2008, 130 (49) : 16691 - 16696
  • [42] Synthesis and activity of substituted carbamates as potentiators of the α4β2 nicotinic acetylcholine receptor
    Springer, Stephanie K.
    Woodin, Katrina S.
    Berry, Virginia
    Boezio, Alessandro A.
    Cao, Lei
    Clarkin, Kristie
    Harmange, Jean-Christophe
    Hierl, Markus
    Knop, Johannes
    Malmberg, Annika B.
    McDermott, Jeff S.
    Nguyen, Hung Q.
    Waldon, Daniel
    Albrecht, Brian K.
    McDonough, Stefan I.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2008, 18 (20) : 5643 - 5647
  • [43] Nicotine effects on human endothelial intercellular communication via α4β2 and α3β2 nicotinic acetylcholine receptor subtypes
    Duerrschmidt, Nicole
    Hagen, Anja
    Gaertner, Christiane
    Wermke, Alice
    Nowicki, Marcin
    Spanel-Borowski, Katharina
    Stepan, Holger
    Mohr, Friedrich-Wilhelm
    Dhein, Stefan
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2012, 385 (06) : 621 - 632
  • [44] Rare Human Nicotinic Acetylcholine Receptor α4 Subunit (CHRNA4) Variants Affect Expression and Function of High-Affinity Nicotinic Acetylcholine Receptors
    McClure-Begley, T. D.
    Papke, R. L.
    Stone, K. L.
    Stokes, C.
    Levy, A. D.
    Gelernter, J.
    Xie, P.
    Lindstrom, J.
    Picciotto, M. R.
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2014, 348 (03): : 410 - 420
  • [45] Deconstruction of the α4β2 Nicotinic Acetylcholine Receptor Positive Allosteric Modulator Desformylflustrabromine
    German, Nadezhda
    Kim, Jin-Sung
    Jain, Atul
    Dukat, Malgorzata
    Pandya, Anshul
    Ma, Yilong
    Weltzin, Maegan
    Schulte, Marvin K.
    Glennon, Richard A.
    JOURNAL OF MEDICINAL CHEMISTRY, 2011, 54 (20) : 7259 - 7267
  • [46] β2 subunit contribution to 4/7 α-conotoxin binding to the nicotinic acetylcholine receptor
    Dutertre, S
    Nicke, A
    Lewis, RJ
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2005, 280 (34) : 30460 - 30468
  • [47] Probing Binding Interactions of Cytisine Derivatives to the α4β2 Nicotinic Acetylcholine Receptor
    Blom, Annet E. M.
    Campello, Hugo Rego
    Lester, Henry A.
    Gallagher, Timothy
    Dougherty, Dennis A.
    JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2019, 141 (40) : 15840 - 15849
  • [48] Effect of galantamine on the human α7 neuronal nicotinic acetylcholine receptor, the Torpedo nicotinic acetylcholine receptor and spontaneous cholinergic synaptic activity
    Texidó, L
    Ros, E
    Martín-Satué, M
    López, S
    Aleu, J
    Marsal, J
    Solsona, C
    BRITISH JOURNAL OF PHARMACOLOGY, 2005, 145 (05) : 672 - 678
  • [49] Novel Acetylcholine and Carbamoylcholine Analogues: Development of a Functionally Selective α4β2 Nicotinic Acetylcholine Receptor Agonist
    Hansen, Camilla P.
    Jensen, Anders A.
    Christensen, Jeppe K.
    Balle, Thomas
    Lijefors, Tommy
    Frolund, Bente
    JOURNAL OF MEDICINAL CHEMISTRY, 2008, 51 (23) : 7380 - 7395
  • [50] Stable expression, pharmacologic properties and regulation of the human neuronal nicotinic acetylcholine alpha(4)beta(2) receptor
    Gopalakrishnan, M
    Monteggia, LM
    Anderson, DJ
    Molinari, EJ
    PiattoniKaplan, M
    DonnellyRoberts, D
    Arneric, SP
    Sullivan, JP
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 1996, 276 (01): : 289 - 297